# Thyroid Hormones in CKD

> **NCT07663773** · — · NOT_YET_RECRUITING · sponsor: **Mario Negri Institute for Pharmacological Research** · enrollment: 51 (estimated)

## Conditions studied

- Chronic Kidney Disease (Stages 4 and 5)

## Interventions

- **OTHER:** Laboratory measurements

## Key facts

- **NCT ID:** NCT07663773
- **Lead sponsor:** Mario Negri Institute for Pharmacological Research
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2027-09
- **Final completion:** 2027-09
- **Target enrollment:** 51 (ESTIMATED)
- **Last updated:** 2026-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07663773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07663773, "Thyroid Hormones in CKD". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07663773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
